The company overcame early funding challenges with the help of influential backing.
{iframe}https://www.bizjournals.com/washington/news/2018/02/09/gaithersburg-biotech-raises-21-7m-from-a-whos-who.html{/iframe}
Teva Pharmaceuticals chairman, former Medtronic CEO invest in NexImmune – Washington Business Journal